Karen Joy Shaw

The Combination Treatment of Fosmanogepix and Liposomal Amphotericin B Is Superior to Monotherapy in Treating Experimental Invasive Mold Infections

Manogepix, the Active Moiety of the Investigational Agent Fosmanogepix, Demonstrates <i>In Vitro</i> Activity against Members of the Fusarium oxysporum and Fusarium solani Species Complexes

Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections

Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial

Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus

Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of <i>Candida</i> Endophthalmitis and Hematogenous Meningoencephalitis in Nonneutropenic Rabbits

Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis

APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental <i>Coccidioides immitis</i> Pneumonia

Analysis of Commercial Kidney Stone Probiotic Supplements

Amicoumacin A Inhibits Translation by Stabilizing mRNA Interaction with the Ribosome

Identifying the targets of aminoacyl-tRNA synthetase inhibitors by primer extension inhibition